pegawai sains
jabatan kejuruteraan tisu & perubatan regeneratif
asyrafafandi@ukm.edu.my
Biografi/ Biography :
PEGAWAI SAINS
manira binti maarof;ng shiow fern;ng min hwei;mohd fauzi bin mh busra;nurwahyuna binti rosli;mohd asyraf bin mat afandi;yogeswaran a/l lokanathan. (2024). shelf-life and safety evaluation of the dermal fibroblast conditioned medium (dfcm) for future skin regeneration and rejuvenation. - . .
wan tai seet, mohd asyraf mat afandi, mohamad fikeri ishak, muhammad najib fathi hassan, nazeha ahmat, min hwei ng and manira maarof. (2023). quality management overview for the production of a tissue-engineered human skin substitute in malaysia. - stem cell research & therapy. 1-14.
yogeswaran lokanathan, alvin chan man lung, angela ng min hwei, mohd heikal mohd yunus, ruszymah hj idrus, law jia xian, muhammad dain yazid, chin kok yong, sharen aini shamsuddin, rafizul mohd yusof, rabiatul adawiyah razali, mohd asyraf. (2023). allogeneic wharton's jelly-derived mesenchymal stem cell as cell therapy: safety study in an animal model. - international conference on molecular medicine and therapeutics (icmt-2023). 1.
alvin cml, angela ng mh, mohd heikal my, ruszymah hj bt idrus, law jia xian, muhammad dain yazid, chin kok-yong, sharen aini shamsuddin, mohd rafizul mohd yusof, mohd asyraf mat afandi, muhammad najib fathi hassan, ng see nguan, benson, yogeswaran. (2022). pre-clinical safety study of wharton's jelly-derived mesenchymal stem cells delivered via systemic administration. - malaysian journal of medicine and health sciences. 3.
alvin chan, angela ng, mohd heikal mohd yunus, ruszymah idrus, jia xian law, muhammad dain yazid, kok-yong chin, sharen, mohd rafizul mohd yusof, rabiatul adawiyah razali, mohd asyraf mat afandi, muhammad najib fathi, see nguan ng, benson koh, yogeswaran. (2022). safety study of allogeneic mesenchymal stem cell therapy in animal model. - regenerative therapy. 158-165.
wan tai seet, mohd asyraf mat afandi, mohamad fikeri ishak, muhammad najib fathi hassan, nazeha ahmat, min hwei ng and manira maarof. (2023). quality management overview for the production of a tissue-engineered human skin substitute in malaysia. - stem cell research & therapy. 1-14.
alvin chan, angela ng, mohd heikal mohd yunus, ruszymah idrus, jia xian law, muhammad dain yazid, kok-yong chin, sharen, mohd rafizul mohd yusof, rabiatul adawiyah razali, mohd asyraf mat afandi, muhammad najib fathi, see nguan ng, benson koh, yogeswaran. (2022). safety study of allogeneic mesenchymal stem cell therapy in animal model. - regenerative therapy. 158-165.
wan tai seet, mohd asyraf mat afandi, mohamad fikeri ishak, muhammad najib fathi hassan, nazeha ahmat, min hwei ng and manira maarof. (2023). quality management overview for the production of a tissue-engineered human skin substitute in malaysia. - stem cell research & therapy. 1-14.
alvin chan, angela ng, mohd heikal mohd yunus, ruszymah idrus, jia xian law, muhammad dain yazid, kok-yong chin, sharen, mohd rafizul mohd yusof, rabiatul adawiyah razali, mohd asyraf mat afandi, muhammad najib fathi, see nguan ng, benson koh, yogeswaran. (2022). safety study of allogeneic mesenchymal stem cell therapy in animal model. - regenerative therapy. 158-165.
alvin cml, angela ng mh, mohd heikal my, ruszymah hj bt idrus, law jia xian, muhammad dain yazid, chin kok-yong, sharen aini shamsuddin, mohd rafizul mohd yusof, mohd asyraf mat afandi, muhammad najib fathi hassan, ng see nguan, benson, yogeswaran. (2022). pre-clinical safety study of wharton's jelly-derived mesenchymal stem cells delivered via systemic administration. - malaysian journal of medicine and health sciences. 3.
wan tai seet, mohd asyraf mat afandi, sharen aini shamsuddin, yogeswaran lokanathan, min hwei ng, manira maarof. (2022). stem cell production - processes, practices and regulations. - . 32.
manira binti maarof;ng shiow fern;ng min hwei;mohd fauzi bin mh busra;nurwahyuna binti rosli;mohd asyraf bin mat afandi;yogeswaran a/l lokanathan. (2024). shelf-life and safety evaluation of the dermal fibroblast conditioned medium (dfcm) for future skin regeneration and rejuvenation. - . .
yogeswaran lokanathan, alvin chan man lung, angela ng min hwei, mohd heikal mohd yunus, ruszymah hj idrus, law jia xian, muhammad dain yazid, chin kok yong, sharen aini shamsuddin, rafizul mohd yusof, rabiatul adawiyah razali, mohd asyraf. (2023). allogeneic wharton's jelly-derived mesenchymal stem cell as cell therapy: safety study in an animal model. - international conference on molecular medicine and therapeutics (icmt-2023). 1.
mohd asyraf ma. (2017). synergistic effect of laminin and epidermal growth factor (egf) on co-cultured myoblasts and fibroblasts. - tissue engineering and regenerative medicine international society-asia pacific meeting (termis-ap 2017). .
mohd asyraf ma, kamalia z, ruszymah bhi and chowdhury sr. (2016). laminin and epidermal growth factor (egf) preferentially enhances migration & proliferation of myoblasts. - 6th malaysian tissue engineering and regenerative medicine scientific (mterms) meeting and 2nd malaysian stem cell meeting. .
kamalia z, mohd asyraf ma, ruszymah bhi and chowdhury sr. (2016). muscle cells conditioned medium (mccm) on angiogenesis. - 6th malaysian tissue engineering and regenerative medicine scientific (mterms) meeting and 2nd malaysian stem cell meeting. .